Charles River Laboratories | CRL - Market Capitalization

Stock Price
153.96
Daily Change
1.99 1.31%
Monthly
-2.56%
Yearly
-12.99%
Q1 Forecast
150.77

Charles River Laboratories reported $7.89B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Cardinal Health USD 48.83B 11.54B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Cigna USD 73.52B 3.42B Dec/2025
Concord Medical Services Hldg CNY 59.92M 11.29M Jun/2023
CVS Health USD 100.74B 5.12B Dec/2025
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.28B 251M Dec/2025
Elevance Health USD 77.91B 5.15B Dec/2025
Galapagos EUR 1.89B 49.73M Mar/2026
Hologic USD 16.62B 1.67B Dec/2025
Humana USD 30.81B 485M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 101.25B 5.15B Dec/2025
Merck EUR 47.3B 6B Mar/2026
Mettler Toledo International USD 28.48B 3.19B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
UnitedHealth USD 299.03B 14.21B Dec/2025
Veradigm USD 525M 621M Mar/2026
Waters USD 22.61B 5.25B Dec/2025
West Pharmaceutical Services USD 19.8B 932M Dec/2025